Innovative Pediatric Lupus Research Fueled by Lupus Canada Grant

Innovative Pediatric Lupus Research Funded by Lupus Canada

On June 29, 2026, Lupus Canada announced the recipient of the prestigious 2026 Lupus Canada Catalyst Grant, awarded to Dr. Andrea Knight, an Associate Professor in the Division of Rheumatology at The Hospital for Sick Children (SickKids) and the University of Toronto. This grant, in collaboration with the Lupus Foundation of America, will support Dr. Knight's study titled A New Approach to Functional Brain Imaging in Childhood-Onset Lupus. The research seeks to unravel the complexities of cognitive dysfunction within children and adolescents diagnosed with systemic lupus erythematosus (cSLE).

Lupus is known to affect children and teenagers more severely than adults, manifesting in more intense symptoms and posing increased risks for long-term developmental effects. One of the prevalent yet under-recognized issues faced by young lupus patients is cognitive decline due to inflammation in the brain. Unfortunately, the root causes of these cognitive challenges remain inadequately understood.

Dr. Knight's research leverages cutting-edge technology known as Optically Pumped Magnetometer-Magnetoencephalography (OPM-MEG). This non-invasive method will allow for new insights into brain function by comparing brain activity between cSLE patients and healthy peers. The objective is to pinpoint variations in brain activity during different tasks and at rest, ultimately identifying the changes associated with cognitive dysfunction.

“From my clinical experience, I frequently encounter young patients with lupus who struggle significantly with fatigue, concentration issues, and emotional difficulties. These challenges significantly disrupt their academic and personal lives,” Dr. Knight stated. “The Lupus Canada Catalyst Grant is crucial in providing early-stage support for lupus research, enabling us to gather foundational data non-invasively to understand better why cognitive dysfunction occurs and to develop effective therapeutic strategies for young individuals living with this debilitating disease.”

Understanding the impact of lupus on cognitive function during adolescence can be a game changer in enhancing individual patient care. According to Leanne Mielczarek, CEO of Lupus Canada, “Children and adolescents living with lupus encounter challenges that substantially affect their daily life, including their academic performance, social interactions, and overall well-being. Dr. Knight's research holds promise for informing more effective interventions and support strategies, enabling young lupus patients to attain better life outcomes.”

Dr. Knight's study is expected to shed light on the disabling aspects of cognitive dysfunction linked to lupus, which often remains a high-priority yet unmet need for affected children and their families. This initiative aligns with the broader goals of Lupus Canada and the Lupus Foundation of America, which continue to advocate for enhanced research, awareness, and education about the complexities of lupus.

The Lupus Canada Catalyst Grant serves as a critical funding source for Canadian lupus researchers at any stage of their careers. Its aim is to foster innovative research capable of improving the quality of life for those impacted by lupus. The program, now in its sixth year, is managed collaboratively with the Lupus Foundation of America, who evaluates and supports the grant process through their esteemed Medical-Scientific Advisory Council.

“The unique challenges that lupus presents in children require urgent attention. Dr. Knight's investigation into cognitive changes is pivotal in ensuring enhanced quality of life during these crucial developmental periods,” explained Joy Buie, Vice President of Research at the Lupus Foundation of America. “By prioritizing patient needs, Dr. Knight's research could provide vital insights into a debilitating aspect of lupus, which is a pressing concern for both patients and their caregivers.”

In summary, the grant awarded to Dr. Andrea Knight is a significant step forward in pediatric lupus research. The insights gained from this innovative study could not only enhance the understanding of cognitive dysfunction in youth with lupus but also improve the interventions tailored to support their overall health and quality of life.

For more information about Lupus Canada and the Catalyst Grant program, visit www.lupuscanada.org. For details on the Lupus Foundation of America and their initiatives, explore lupus.org.